Multidrug Resistant Tuberculosis Recruiting Phase 3 Trials for Isoniazid (DB00951)

Also known as: MDR-TB / MDR Tuberculosis / Multidrug-Resistant Tuberculosis / Tuberculosis, Multidrug Resistant / Tuberculosis, MDR / MDR TB / Multi Drug Resistant Tuberculosis / Tuberculosis, Multidrug-Resistant / Multi-Drug Resistant Tuberculosis / TB Multi-drug Resistant / Multidrug resistant tuberculosis (disorder) / Tuberculosis / Tuberculosis (disorder) / Tuberculosis NOS / Tuberculosis NOS (disorder) / Infection TBC / Infection tuberculosis / Infection caused by Mycobacterium tuberculosis (disorder) / TB / Tuberculous (disorder) / Tuberculous (qualifier value) / Tuberculous infections

IndicationStatusPhase
DBCOND0041129 (Multidrug Resistant Tuberculosis)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04260477Novel Triple-dose Tuberculosis Retreatment RegimenTreatment
NCT03568383Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis PatientsPrevention